Search
for

    Sort by

    Research 241–270 of 262

    1. Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature Medicina · 2024
    2. Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023 Irish Journal of Medical Science (1971 -) · 2024
    3. Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system Andrology · 2024
    4. CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway Stem Cell Research & Therapy · 2024
    5. Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database Skin Appendage Disorders · 2024
    6. The possibilities of correction of premature greying of hair and involutive hair changes Medical alphabet · 2024
    7. Resolution of Discoid Lupus Alopecia With Systemic Hydroxychloroquine and Topical Pimecrolimus Combination Therapy Cureus · 2024
    8. Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies Current issues in molecular biology · 2024
    9. Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs Frontiers in pharmacology · 2023
    10. Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns Pharmacoepidemiology and Drug Safety · 2023
    11. Treatments for alopecia areata: a network meta-analysis The Cochrane library · 2023
    12. 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2023
    13. An Updated in the Management of Alopecia Areata IntechOpen eBooks · 2023
    14. Hair Disorders in Autoimmune Diseases Skin appendage disorders · 2023
    15. MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata 2023
    16. Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape Wound practice & research · 2022
    17. Influência da Disbiose na Patologia do Couro Cabeludo Revista da Sociedade Portuguesa de Dermatologia e Venereologia · 2021
    18. https://researchopenworld.com/genetics-of-hidradenitis-suppurativa/# 2020
    19. Cells to Surgery Quiz: April 2020 2020
    20. Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años Dermatology Online Journal · 2018
    21. Subject Index Journal of the American Academy of Dermatology · 2009
    22. British Association of Dermatologists living guideline for managing people with alopecia areata 2025 British Journal of Dermatology · 2025
    23. Response to ustekinumab in three pediatric patients with alopecia areata Pediatric dermatology · 2018 · 25 citations
    24. Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata JAAD case reports · 2017 · 20 citations
    25. Onset of frontal fibrosing alopecia during inhibition of Th1/17 Pathways with ustekinumab Dermatology Online Journal · 2019 · 7 citations
    26. Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease Journal of Biomedicine and Biotechnology · 2012 · 6 citations
    27. Comparative Effects of Ustekinumab and Vedolizumab on Alopecia in Ulcerative Colitis: A Systematic Review and Meta-Analysis Journal of Pharmaceutical Research International · 2025
    28. Impact of ustekinumab on quality of life and sexual difficulties associated with psoriasis: Results from phase III clinical trials Journal of The American Academy of Dermatology · 2010
    29. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment Gut · 2013 · 278 citations
    30. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Journal of the American Academy of Dermatology · 2019 · 256 citations